GLP-1 medications may cause rapid weight loss, which can result in a hollowed look to the face, sunken eyes, wrinkles, sagging skin and changes in the size of your lips, cheeks and chin
J Small Anim Pract 65(3):153175 Pei J, Pan X, Wei G, Hua Y (2023) Research progress of glutathione peroxidase family (GPX) in redoxidation
A: If you miss a dose, take it as soon as you remember on the same day
Semaglutide Dosing# FDA-approved dosing with established protocols: Ozempic (T2D) : Start 0.25 mg weekly, escalate to 0.5-2 mg over 8-16 weeks Wegovy (obesity) : Start 0.25 mg weekly, escalate through 0.5, 1.0, 1.7, to 2.4 mg maintenance over 16 weeks Rybelsus (oral T2D) : Start 3 mg daily, escalate to 7-14 mg daily over 30-60 days Semaglutide benefits from established guidelines for missed doses, switching between formulations, special populations (renal/hepatic impairment, elderly), and drug interactions
The FDA classifies semaglutide as Category C for pregnancy, meaning animal studies have shown some risk but human data is limited
Recent case reports and observational studies have documented instances of unexpected gastric content retention and aspiration events in patients taking GLP-1 RAs